Thyroglossal duct cysts are one of the most common congenital abnormalities of the cervical region. Complications of these swellings are rare, and among these, appearance of a carcinoma has also been noted. Thyroglossal duct cyst carcinoma (TGDC) is a rare entity and its management is controversial. The incidence of thyroid papillary carcinoma in thyroglossal duct cyst is less than 1%, in most cases, the diagnosis is made postoperatively. We report the case of an adult female patient with a papillary carcinoma arising in a thyroglossal duct cyst. Our aim is defining a clinical protocol to diagnose the thyreoglossal duct carcinoma through clinical features, radiological investigations, cytological and histopathological examinations and, through this diagnostic protocol, to choose the best surgical approach. The literature contains 300 cases of this pathology; papillary histotype constitutes about 80%, then squamocellular carcinoma, mixed folliculo-papillary carcinoma and adenocarcinoma follow. The literature suggests two different hypotheses: neoplasia originating from ectopic thyroid tissue and plurifocal theory. The adopted diagnostic investigations are: ultrasonography, Fine Needle Aspiration Biopsy (FNAB), Magnetic Resonance Imaging (MRI). Our patient was treated using a modified Sistrunk's procedure operation, in which thyroidectomy proved crucial for the correct diagnosis and continuation of appropriate treatment. Our case confirms the difficulty in distinguishing a primitive thyroglossal duct carcinoma from a synchronous metastatic papillary carcinoma of the thyroid. This dilemma often remains unresolved. The two different surgical approaches reported in the literature, one more conservative and the other more aggressive, apparently alternatives are instead complementary and adequate when strict 
Introduction
Recent biomolecular studies have identified the bio-genetical mechanisms of thyroid morphogenesis and differentiation; this gives us the opportunity to understand thyroid malformative abnormalities due to morpho-genetical errors.
These errors cause an abnormal dislocation of the primordial median rudimentary thyroid, determining the development of thyroid tissue in different districts (lingual, mediastinal ad also intracardiac). In some cases, for this same reason, due to these genetic errors, if the duct fails to obliterate, it may give rise to the development of a fistular passage (thyroglossal duct cyst). The thyroglossal duct cyst is the outcome of the persistence and of the cystic growth of the remnants of the thyroglossal tract [1] [2] [3] . Recently, specific follicular thyroid cell transcriptional factors have been identified which are responsible, selectively, for the thyroid genic expression of TTF-1, TTF-2 and PAX-8, each one of these genes is also expressed in stem cells and are different from the follicular thyroid cells, the association of these three factors is characteristic of the hormonogenetic thyroid cells [4] [5] [6] . The thyroglossal duct cyst is one of the most common congenital malformation cervical (about 70%), 50% of these cases appearing in patients aged 20 or younger and the prevalence of location of the cyst is along the midline (75%), in para-median position in the remaining 25%. The thyroglossal duct cyst papillary carcinoma incidence is about 1%. This neoplasia is characterized by a relatively non aggressive behavior with rare involvement of the thyroid gland and locoregional lymphnodes spread. Brentano, in 1911 , defined the first carcinoma of the thyroglossal duct [7] . This carcinoma can appear during the childhood, but the peak incidence is between the forth and the fifth decades, females are affected slightly more often than males, with a 3:2 ratio [8] . The papillary hystotype is about 80% of all the thyroglossal carcinomas, followed by mixed folliculo-papillary carcinoma (8%), squamocellular carcinoma (6%) and the remaining 6% concerns Hurtle cells carcinoma, follicular carcinoma and anaplastic carcinoma [9] [10] [11] . 
Case Report
A 40 years old woman presents before us with a 5 years' history of a great anterior midline neck mass, enlarging during the last months. At the physical examination we can see an ovoidal mass, located in hyoid region, covered by normal skin, about 5 cm in diameter; palpation reveals a painless, mobile, non-tender, elastic mass. Ultrasound guided Fine Needle Aspiration Biopsy demonstrates that the lesion is arising, probably, in a thyroglossal duct, however some cytocariological abnormalityes are displayed in some foci, in particular, there is a moderate grade of anemacrocytosis with ground glass nuclei, worthy of further hystologic diagnostic deepening in order to reject a concomitant intracystic papillary carcinoma. A RMI, performed with and without paramagnetic contrast (Gd-DPTA), integrated by neck T1-weighted FAT-SAT acquisitions, shows cystic ovoidal lesion with regular border, located along the median cervico-anterior line of the neck below the hyoid bone, having transverse diameter about 3 cm long, and extending 6 cm, craniocaudally, hyperintense signalling on T2-weightened, omogeneous on T1-weightened, without mdc, acquisitions, insinuating itself inside the strap muscle in infrahyoidal region. Inside the lesion a solid nest is recognizable (at infra-hyoid epiglottic axial plane levels) developing in the median and paramedian right region, having maximum transverse diameter of about 13 mm and showing clear, marked enhancement after the administration of the mdc i.v. These RM findings are related to the presence of a large median cystic lesion in the neck: probably thyroglossal duct cyst with solid nucleus demonstrating clear enhancement after the administration of mdc i.v. This finding does not allow excluding that the lesion lies inside an ectopic remnant of thyroid tissue contained in a thyroglossal duct cyst. Some lymphnodes, moderately greater in number and in size, are present, bilaterally, at level I and II ( Figure 1 and Figure 2 ). The patient, therefore, undergoes median cervicotomy 
Discussion
The thyroglossal duct carcinoma management is greatly debated, particularly when thyroid gland is clinically normal. Some authors support the thesis that tyroglossal duct carcinoma originates within ectopic thyroid tissue, contained inside the cyst; other authors sustain the thesis of a metastasis deriving from the thyroid gland. Accordingly, the surgical approach too is greatly debated: some authors think adeguate the so called Sistrunk's procedure when thyroid gland is normo-functioning. In 1920 Sistrunk [12] described a procedure to remove a thyroglossal cyst, which was based on the embriologic origin knowledge of the lesion. In this procedure the cyst, the median portion of hyoid bone and the tract of the thyroglossal duct, extending from the foramen cecum at the base of the tongue, to the hyoid bone, are removed in continuity. is necessary for patients with thyroid carcinoma arising in a TGDC [23] . In view of the frequent co-existence of thyroid cancer in these patients, we would recommend detailed thyroid evaluation and, eventually, total thyroidectomy at initial diagnosis of TGDC carcinoma (Table 1 ).
Conclusion
Our aim is to emphasize that significant attention must be paid to the pre-operative evaluation of the patient, the conclusions of the diagnostic phase can directly address towards the first choice surgery. The preoperative protocol we have done has given us the suspect of the presence of an intracystic thyroglossal duct papillary neoplasia, the hystopathologic examination of the material obtained during surgery confirmed, in fact, our pre-surgical diagnosis. So we have had the confirmation that ultrasonography, FNAB and MRI are essential to choose the surgical strategy and, at the same time, to achieve the definitive diagnosis of the lesion. Surgical Sistrunk's procedure is adequate when thyroid gland is clinically and radiologically normal. Papillary thyroid carcinoma arising in thyroglossal duct cysts is a very rare malignant tumor. In spite of the multifocal character of several of our cases, their analysis showed that the In 10% -40% of the patients who undergo a subsequent thyroidectomy, malignant focuses are also found I the thyroid. In view of this multifocal occurrence and the fact that in most cases the diagnosis of carcinoma is only made after the operation, which often implies uncertainty about oncological radicalness, the authors advice to perform a near (-total) thyroidectomy as the standard procedure in case of thyriglossal duct carcinoma. After this adequate treatment with 131I should be given.
Foggia (Italy) Cignarelli (2002) 3 cases
Rapid growth of the cystic nass, and the presence of a mural nodule on US, especially with calcifications, must raise the physician's suspicion for a cancer arising in TDC.
Aluffi 13 (2003) Two cases, currenttly, most authors agree about their primary origin ex novo from ectopic thyroid tissue in the ctst. In most cases the diagnosis of thyroglossal duct carcinoma (TD) is not mede until histopathological examination has been performed on a resected cyst without any suspected clinical sign of malignancy. The definition of the correct surgical treatment for these carcinomas is still controversial. Most authors maintain that resection of a TDC with the Sistrunk procedure can be considered oncologically adequate then dealing with a differentiated carcinoma without extracapsular invasion and/or lymphonode metastase and with a normal thyroid.
Duzce (Turkey)
Ozturk (2003) 11 M After a primary Sistrunk procedure, the cyst and tract extending to the forame caecum at the base of the tongue in continuity with the midportion of the hyod bone were resected.
Naghavi (2003) 28 M
We recommend that thyroglossal duct cyst with a microscopic focus of papillary carcinoma without cyst wall invasion be managed with Sistrunk procedure along with effective suppressant dose of thyroxine. Open Access Library Journal Extent of surgery in thyroglossal duct carcinoma: reflections on a series on a series eighteen cases. Thyroglossal duct neoplasm was represented by papillary carcinoma in 16 cases; thyroid histology demonstrated papillary carcinoma in 6 cases (33.3%).
Mazzaferri (2004)
Thyroid cancer in thyroglossal duct remnants: a diagnostic and therapeutic dilemma.
Peretz (2004)
Tyroglossal duct carcinoma in children.
Belnoue (2004) 4 cases od papillary thyroglossal duct: one patient needed a thyroidectomy fifteen years after the initial management of the PTDC; 2 patients were treated by a Sistrunk procedure associated with total thyroidectomy. A microscopic focus of papillary carcinoma without cyst wall invasion, can be managed bi Sistrunk procedure with the need for long-term follow-up. Treatment of all other thyroglossal duct papillary carcinoma should include thyroidectomy followed by radioactive iodine treatment.
Shahin (2005)
Thyroglossal duct cyst: a cytopathologic study of 26 cases.
Demir (2005) 2 cases micropapillary carcinoma was detected tyroid gland of both patients. Simultaneous existence of papillary carcinoma in the thyroid gland and thyroglossal duct cyst in two patients.
Plaza ( SPECT/CT precisely localized neck iodine uptake. In small numbers of patients, treatment is affected. Spect/CT should be used when available in thyroid carcinoma patients. In three of 13 studies with neck uptake, SPECT/CT provided no useful additional information. There were ten patients who were diagnosed with TGDC carcinoma at our institution. All patients underwent pre-operative fine-needle aspiration biopsy (FNAB). Nine patients were suspected of having papillary carcinoma following cytology. The Sistrunk operation (SO) was performed in four patients, SO with total thyroidectomy (SO/TT) was performed in three patients, and SO/TT with neck dissection was performed in three patients.
Busan, (Republic of Korea). Long-term follow-up is necessary for patients with thyroid carcinoma arising in a TGDC. In view of the frequent co-existence of thyroid cancer in these patients, we would recommend detailed thyroid evaluation and, eventually, total thyroidectomy at initial diagnosis of TGDC carcinoma. Moreover, we found no relation between outcome and surgical procedure.
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